G. Thomas Budd on Genomic Profiling for Targeted Therapies

Video

G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.

G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.

Genomic profiling is not commonly done because of the expense, Budd says, but there is pressure to make the technology more widely available available to patients.

Budd adds that genomic profiling is still being studied in clinical trials. The NCI-MATCH trial, for example, patients will undergo genomic profiling to determine whether they have a genetic mutation or molecular abnormality that will respond to a targeted drug.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content